Merck's $11.5 Billion Bet on Its Next Big Drug Finally Arrives

The newly approved drug, which treats potentially fatal pulmonary arterial hypertension, is estimated to ring up as much as $7.5 billion in yearly sales. 


 
Apple Turns to Longtime Steve Jobs Disciple to Defend Its 'Walled Garden'

Former Chief Marketing Officer Phil Schiller has frequently made it clear that Apple doesn't intend to yield to developer criticism 


 
Can Apple and AI Make Baidu Cool Again?

China's search leader was long viewed as an also-ran. Shifting political and technological winds might change that. 


 
Musk's xAI to Make Grok Chatbot Available to All Premium X Users

Elon Musk's artificial-intelligence company will make its Grok chatbot available to all premium subscribers of social-media platform X. 


 
UBS, Apollo Complete Securitization Unit Deal

UBS and Apollo Global Management have finalized a deal to offload Credit Suisse's former securitized products business, as the Swiss bank continues its integration after the takeover. 


 
KuCoin and Its Founders Face Criminal Charges Over Money-Laundering Violations

U.S. prosecutors have filed criminal charges against KuCoin and two of its founders, accusing the global cryptocurrency exchange of violating U.S. anti-money-laundering laws. 


 
H&M Outlook on Track as Sales Pick Up

H&M posted forecast-beating earnings as well-received spring collections pushed sales higher during February., and said its target of a 10% operating margin for 2024 remained. 


 
Elon Musk Pushes to Increase Use of 'Full Self-Driving' Software as Tesla Sales Cool

Elon Musk has said drivers with FSD enabled will get a one-month free trial starting in the coming days. 


 
NBC Drops Former RNC Chief Ronna McDaniel Amid Backlash

Hiring of former Republican National Committee Chairwoman sparked an unprecedented on-air backlash from anchors and commentators. 


 
Krispy Kreme Stock Jumps After Expanding Partnership With McDonald's

The fast-food chain said it will start rolling out the doughnuts in the second half of this year.


(END) Dow Jones Newswires

03-27-24 0715ET